Variable response to antiplatelet therapy: What does it mean to clinicians?

Nezar Falluji, MD, MPH
Linda and Jack Gill Heart Institute, University of Kentucky, Lexington

Steven R. Steinhubl, MD
Linda and Jack Gill Heart Institute, University of Kentucky, Lexington

Address: Steven R. Steinhubl, MD, 900 South Limestone Street, 326 Charles T. Wethington Building, Lexington, KY 40536-0200; e-mail: Steinhubl@uky.edu

Dr. Steinhubl has indicated that he has received honoraria from and has acted as a consultant for Sanofi-Aventis and Eli Lilly corporations.

Nezar Falluji, MD, MPH
Linda and Jack Gill Heart Institute, University of Kentucky, Lexington

Steven R. Steinhubl, MD
Linda and Jack Gill Heart Institute, University of Kentucky, Lexington

Address: Steven R. Steinhubl, MD, 900 South Limestone Street, 326 Charles T. Wethington Building, Lexington, KY 40536-0200; e-mail: Steinhubl@uky.edu

Dr. Steinhubl has indicated that he has received honoraria from and has acted as a consultant for Sanofi-Aventis and Eli Lilly corporations.

Nezar Falluji, MD, MPH
Linda and Jack Gill Heart Institute, University of Kentucky, Lexington

Steven R. Steinhubl, MD
Linda and Jack Gill Heart Institute, University of Kentucky, Lexington

Address: Steven R. Steinhubl, MD, 900 South Limestone Street, 326 Charles T. Wethington Building, Lexington, KY 40536-0200; e-mail: Steinhubl@uky.edu

Dr. Steinhubl has indicated that he has received honoraria from and has acted as a consultant for Sanofi-Aventis and Eli Lilly corporations.